Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $126.16 million. The enterprise value is -$122.25 million.

Market Cap	126.16M
Enterprise Value	-122.25M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

NMRA has 161.75 million shares outstanding. The number of shares has increased by 64.89% in one year.

Current Share Class	161.75M
Shares Outstanding	161.75M
Shares Change (YoY)	+64.89%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	5.31%
Owned by Institutions (%)	42.84%
Float	85.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.55
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.98, with a Debt / Equity ratio of 0.00.

Current Ratio	8.98
Quick Ratio	8.78
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.05% and return on invested capital (ROIC) is -52.09%.

Return on Equity (ROE)	-79.05%
Return on Assets (ROA)	-48.50%
Return on Invested Capital (ROIC)	-52.09%
Return on Capital Employed (ROCE)	-120.13%
Revenue Per Employee	n/a
Profits Per Employee	-$2.35M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $283,000 in taxes.

Income Tax	283,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-91.68%
50-Day Moving Average	0.75
200-Day Moving Average	5.81
Relative Strength Index (RSI)	46.50
Average Volume (20 Days)	871,894

Short Selling Information

The latest short interest is 15.02 million, so 9.29% of the outstanding shares have been sold short.

Short Interest	15.02M
Short Previous Month	13.66M
Short % of Shares Out	9.29%
Short % of Float	17.49%
Short Ratio (days to cover)	17.89

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-274.33M
Pretax Income	-273.79M
Net Income	-258.06M
EBITDA	-273.70M
EBIT	-274.33M
Earnings Per Share (EPS)	-$1.61

Full Income Statement

Balance Sheet

The company has $249.35 million in cash and $938,000 in debt, giving a net cash position of $248.42 million or $1.54 per share.

Cash & Cash Equivalents	249.35M
Total Debt	938,000
Net Cash	248.42M
Net Cash Per Share	$1.54
Equity (Book Value)	228.36M
Book Value Per Share	1.41
Working Capital	226.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$199.43 million and capital expenditures $775,000, giving a free cash flow of -$198.65 million.

Operating Cash Flow	-199.43M
Capital Expenditures	775,000
Free Cash Flow	-198.65M
FCF Per Share	-$1.23

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-64.89%
Shareholder Yield	-64.89%
Earnings Yield	-204.54%
FCF Yield	-157.46%

Analyst Forecast

The average price target for NMRA is $9.29, which is 1,091.03% higher than the current price. The consensus rating is "Buy".

Price Target	$9.29
Price Target Difference	1,091.03%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-35.30%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1